Alibaba-backed Chinese robotics firm Dexmal seeks 20 billion yen valuation in ongoing funding talks after prior round with Z.AI Co.
Chinese robotics startup Dexmal is targeting a valuation of approximately 20 billion yen ($3 billion) in its current funding round. The company, backed by Alibaba, is in ongoing discussions with investors, though terms remain subject to change.
The funding effort follows a previous round that included participation from Z.AI Co., also known as Zhipu, a Chinese artificial intelligence lab. Dexmal’s push for a $3 billion valuation reflects growing investor interest in AI-driven robotics.
No immediate market reaction was reported, but the funding round underscores expanding capital flows into China’s tech and automation sectors.